Wannes Vanderhaeghen

Dr. Wannes Vanderhaeghen


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in The Veterinary Journal
Verified
Journal Article
Closed access
WVWannes Vanderhaeghen
Wannes Vanderhaeghen
SPSofie Piepers
Sofie Piepers
Frédéric LeroyFrédéric Leroy
Frédéric Leroy
ECEls Van Coillie
Els Van Coillie
FHFreddy Haesebrouck
Freddy Haesebrouck
SVSarne De Vliegher
Sarne De Vliegher

1 January 2013 in Frontiers in Microbiology
Verified
Journal Article
Open access
FCFlorence Crombé
Florence Crombé
MAMaria Angeles Argudín
Maria Angeles Argudín
WVWannes Vanderhaeghen
Wannes Vanderhaeghen
KHKatleen Hermans
Katleen Hermans
FHFreddy Haesebrouck
Freddy Haesebrouck
Patrick ButayePatrick Butaye
Patrick Butaye
From the mid-2000s on, numerous studies have shown that methicillin-resistant Staphylococcus aureus (MRSA), renowned as human pathogen, has a reservoir in pigs and other livestock. In Europe and North America, clonal complex (CC) 398 appears to be the predominant lineage involved. Especially worrisome is its capacity to contaminate humans in close contact with affected animals. Indeed, the typical multi-resistant phenotype of MRSA CC398 and its observed ability of easily acquiring genetic material suggests that MRSA CC398 strains with an increased virulence potential may emerge, for which few therapeutic options would remain. This questions the need to implement interventions to control the presence and spread of MRSA CC398 among pigs. MRSA CC398 shows a high but not fully understood transmission potential in the pig population and is able to persist within that population. Although direct contact is probably the main route for MRSA transmission between pigs, also environmental contamination, the presence of other livestock, the herd size, and farm management are factors that may be involved in the dissemination of MRSA CC398. The current review aims at summarizing the research that has so far been done on the transmission dynamics and risk factors for introduction and persistence of MRSA CC398 in farms.

27 October 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
JEROEN DEWULFJEROEN DEWULF
JEROEN DEWULF
PJPhilip Joosten
Philip Joosten
ICIlias Chantziaras
Ilias Chantziaras
EBElise Bernaerdt
Elise Bernaerdt
WVWannes Vanderhaeghen
Wannes Vanderhaeghen
Dominiek MaesDominiek Maes
Dominiek Maes
The goal of this study is to describe the current use of antibiotics in the European pig industry based on an extensive literature review. To achieve this, an overview of results from national (n = 15) and multi-country (n = 2) cross-sectional and longitudinal (n = 2) surveys, which describe antimicrobial use in pigs, is presented. Results are further linked to the outcome of the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project. Overall, it was found that weaned piglets received the most antibiotics, followed by suckling piglets resulting in over 80% of the treatments being administered to animals before 10 weeks of age. Furthermore, it was observed that antibiotic use (ABU) was significantly associated across age categories, indicating that farms with a high use in piglets also used more antibiotics in their finishers. This may, among other things, be explained by farmers’ habits and behavior. However, above all, the studies showed surprisingly large differences in ABU between the countries. These differences may be related to the differences in disease prevalence and/or differences in the level of biosecurity. However, they may also reflect variations in rules and regulations between countries and/or a difference in attitude towards ABU of farmers and veterinarians that are not necessarily linked to the true animal health situation. Furthermore, it was observed that already a substantial proportion of the European pig production is able to successfully raise pigs without any group treatments, indicating that it is possible to rear pigs without systematic use of antibiotics. Based on the ESVAC data, a decline of 43.2% was observed in sales of antibiotics for animals in Europe between 2011 and 2020. To enable efficient antimicrobial quantification and stewardship, 15 European countries have already established systems for herd level monitoring ABU in pigs.

1 November 2017 in The Lancet Planetary Health
Verified
Journal Article
Open access
WVWannes Vanderhaeghen
Wannes Vanderhaeghen
JDJeroen Dewulf
Jeroen Dewulf

29 July 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
MDMichèle Driesen
Michèle Driesen
MTMichaël Timmermans
Michaël Timmermans
MCMickaël Cargnel
Mickaël Cargnel
XSXavier Simons
Xavier Simons
MFMaria Eleni Filippitzi
Maria Eleni Filippitzi
CBCécile Boland
Cécile Boland
Linezolid is a critically important antimicrobial used in human medicine. While linezolid is not licensed for food-producing animals, the veterinary use of other antimicrobials, such as phenicols (e.g., florfenicol), could cross/co-select for linezolid-resistant (LR) bacteria. Such LR strains pose a great concern for public health due to their potential transfer between animals and humans. This study explored possible associations between epidemiological risk factors, including phenicol use, and the occurrence of LR bacteria, such as enterococci and staphylococci, in poultry, pigs, and veal calves in Belgium. Florfenicol use significantly increased the likelihood of harboring LR bacteria in veal calves, sows, and fattening pigs, particularly for the digestive tract (odds ratio (OR): [3.19–5.29]) and the respiratory tract (OR: [6.11–9.09]). LR strains from feces from fattening pigs were significantly associated with production type (OR: [3.31–44.14]) and the presence of other animal species (OR: 0.41). The occurrence of LR strains in the respiratory tract from sows was also significantly associated with using antimicrobials other than florfenicol (OR: 10.07) and purchasing animals (OR: 7.28). Our study highlights the potential risks of using certain veterinary antimicrobials, such as florfenicol, in food-producing animals and emphasizes the need for responsible antimicrobial use to safeguard both animal and public health.